What is the downside in Baxter International's stock price?
On average, they anticipate Baxter International's stock price to reach $85.64 in the next twelve months. This suggests that the stock has a possible downside of 1.6%. View Analyst Price Targets for Baxter International.
What are Wall Street's price targets for Baxter International's stock?
15 Wall Street analysts have issued 12-month price targets for Baxter International's shares. Their forecasts range from $70.00 to $95.00. On average, they anticipate Baxter International's stock price to reach $85.64 in the next twelve months. This suggests that the stock has a possible downside of 1.6%.
Who are the insiders of Baxter International?
Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin. View institutional ownership trends for Baxter International. Which institutional investors are selling Baxter International stock?
Does Baxter make premix?
It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. More... Locked.
See more
Is Baxter a good stock to buy?
We believe that Baxter stock is a good buying opportunity at the present time. BAX stock trades near $81 currently and it is, in fact, down 13% from its pre-Covid high of $93 in February 2020 – just before the coronavirus pandemic hit the world.
Is Baxter International a buy?
The 12 analysts offering 12-month price forecasts for Baxter International Inc have a median target of 83.50, with a high estimate of 99.00 and a low estimate of 70.00. The median estimate represents a +30.90% increase from the last price of 63.79.
Does Baxter pay a dividend?
Baxter International Inc. (NYSE:BAX) will pay a dividend of $0.29 on the 3rd of October. This payment means that the dividend yield will be 1.8%, which is around the industry average.
Who is Baxter owned by?
Baxter International Inc.The company is a wholly owned subsidiary of Baxter International Inc., a United States-based pharmaceutical company. IBISWorld partnered with the Australian Financial Review to publish a list of Australia's Top 500 Private Companies for 2019.
Should I buy BAX stock?
Out of 11 analysts, 7 (63.64%) are recommending BAX as a Strong Buy, 2 (18.18%) are recommending BAX as a Buy, 1 (9.09%) are recommending BAX as a Hold, 0 (0%) are recommending BAX as a Sell, and 1 (9.09%) are recommending BAX as a Strong Sell. What is BAX's earnings growth forecast for 2022-2024?
Who is buying HILL ROM?
Baxter International Inc.Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing).
Is Baxter a big company?
1971: Our company joined the Fortune 500 list of the largest American corporations. We also opened an IV solutions manufacturing facility in North Carolina – to this day one of our largest. Our Mini-bag plastic containers came on market in 1974, making ready-to-use premixed drugs available to hospitals.
Is Baxter a Fortune 500 company?
Parkinson Jr. Was this company a 2011 top stock?...Our annual ranking of America's largest corporations.Rank # of Fortune 500 CompaniesNew York502 more rows
Is Baxter a publicly traded company?
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. Baxter International Inc....Baxter International.TypePublicTraded asNYSE: BAX S&P 500 componentIndustryMedical equipmentFounded1931FounderDonald Baxter10 more rows
Should I buy or sell Baxter International stock right now?
14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are curren...
What is Baxter International's stock price forecast for 2022?
14 analysts have issued 12 month price objectives for Baxter International's shares. Their forecasts range from $77.00 to $100.00. On average, they...
How has Baxter International's stock price performed in 2022?
Baxter International's stock was trading at $85.84 at the beginning of 2022. Since then, BAX stock has decreased by 14.8% and is now trading at $73...
Are investors shorting Baxter International?
Baxter International saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 7,200,000 shares,...
When is Baxter International's next earnings date?
Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 28th 2022. View our earnings forecast for...
How can I listen to Baxter International's earnings call?
Baxter International will be holding an earnings conference call on Thursday, July 28th at 8:30 AM Eastern. Interested parties can register for or...
How were Baxter International's earnings last quarter?
Baxter International Inc. (NYSE:BAX) released its quarterly earnings results on Thursday, April, 28th. The medical instruments supplier reported $0...
How often does Baxter International pay dividends? What is the dividend yield for Baxter International?
Baxter International declared a quarterly dividend on Tuesday, May 3rd. Shareholders of record on Friday, June 3rd will be paid a dividend of $0.29...
Is Baxter International a good dividend stock?
Baxter International(NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.61%. Baxter International has bee...
Recently Viewed Tickers
Baxter International Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Where is Baxter located?
Baxter International, Inc.
What is Baxter International?
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.
When will Baxter International release its next quarterly earnings?
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic ...
What is Baxter's earnings per share for 2021?
Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021. View our earnings forecast for Baxter International.
How much does Baxter International make?
Baxter International updated its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share guidance of 3.470-3.550 for the period, compared to the Thomson Reuters consensus estimate of $3.400.
New York Stock Exchange
Baxter International has a market capitalization of $40.80 billion and generates $11.67 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $3.09 on an earnings per share basis.
Environmental, Social, and Governance Rating
The Company provides medical products and services. Its medical devices, pharmaceuticals and biotechnology assists healthcare professionals and their patients in the treatment of complex medical conditions.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
